206 results on '"Cho, Hyun-Woong"'
Search Results
2. Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy
3. Pelvic ultrasound-based deep learning models for accurate diagnosis of ovarian cancer: Retrospective multicenter study.
4. Assessing the New 2020 ESGO/ESTRO/ESP Endometrial Cancer Risk Molecular Categorization System for Predicting Survival and Recurrence
5. Detection of metastatic lymph node and sentinel lymph node mapping using mannose receptor targeting in in vivo mouse and rabbit uterine cancer models
6. A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer
7. DOMENICA study (GINECO-EN105b/ENGOT-en13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1)
8. The effect of the survival outcomes of the neo-adjuvant chemotherapy on the advanced epithelial ovarian cancer
9. A single-arm, phase II study of niraparib and bevacizumab maintenance in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor (KGOG 3056/NIRVANA-R)
10. Oregovomab and non-platinum chemotherapy in PARP inhibitor-resistant ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: a multicenter, two-cohort, single-arm phase 2 trial (OPERA/KGOG 3065/APGOT-OV6)
11. Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy
12. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer
13. A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2
14. Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)
15. Exploring the prognostic significance of preoperative high normocalcemia in epithelial ovarian carcinoma
16. Optimal Dietary Intake of Riboflavin Associated with Lower Risk of Cervical Cancer in Korea: Korean National Health and Nutrition Examination Survey 2010–2021.
17. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN)
18. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis
19. TP017/#812 A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04)
20. PO010/#673 A single-arm, phase II study of niraparib and bevacizumab maintenance in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor (KGOG 3056/NIRVANA-R)
21. EP268/#152 Exploring the impact of surgical interventions and identifying risk factors for recurrence in borderline ovarian tumors
22. TP007/#1383 A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
23. PR039/#272 Value of the new endometrial cancer risk molecular categorization system 2020 ESGO/ESTRO/ESP in predicting survival and recurrence
24. Depressed Mood as a Significant Risk Factor for Gynecological Cancer Aggravation
25. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay
26. Short-Term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in BRCA Mutation Carriers: A Nationwide Study in South Korea
27. Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R)
28. Abstract 2385: Targeting mannose receptor expression on macrophages for sentinel lymph node mapping in endometrial cancer: murine model
29. Pelvic Inflammatory Disease in Virgin Women With Tubo-ovarian Abscess: A Single-Center Experience and Literature Review
30. Comparison of Surgical Outcomes between Single-Port Laparoscopic Surgery and Da Vinci Single-Port Robotic Surgery
31. Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
32. Optimal candidates for conization before radical hysterectomy in early cervical cancer: a Korean multi-center study (COBRA-R)
33. Sentinel lymph node mapping in uterine cancer via indocyanine green-neomannosyl human serum albumin: in vivo mouse model
34. A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial
35. Associated factors with depressed mood in gynecological cancer patients: a retrospective study
36. A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer
37. Robotic radical hysterectomy versus laparoscopic radical hysterectomy in cervical cancer patients: a retrospective comparison of surgical outcomes
38. Oregovomab and non-platinum chemotherapy in PARP inhibitor resistant ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: a multicenter, two-cohort, single-arm phase 2 trial (OPERA/KGOG 3065/APGOT-OV6)
39. Integrative analysis and machine learning application to TCGA DNA methylation, RNA-seq, and variant dataset in endometrial cancer
40. Impact of COVID-19 pandemic on cervical cancer screening - comparison between healthy women and disabled population: a nationwide study in Republic of Korea
41. Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer
42. Short-term hormone replacement therapy in BRCA mutation carriers and risk of breast cancer: a nationwide study in Korea
43. Chemotherapy response score (CRS) is no longer predictive of survival outcomes in patients with BRCA mutation and/or maintenance therapy
44. Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3
45. Learning curves and perioperative outcomes of single-incision robotic sacrocolpopexy on two different da Vinci® surgical systems.
46. Long-term risks of coronary heart disease and cerebrovascular disease in ovarian, uterine and cervical cancer survivors: a nationwide study in Korea
47. Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy
48. The necessity of continuing cervical cancer screening of elderly Korean women aged 65 years or older
49. Clinical indications for hysteroscopic removal of uterine masses: Time, age at diagnosis, and mass size
50. Pivotal Clinical Study to Evaluate the Efficacy and Safety of Assistive Artificial Intelligence-Based Software for Cervical Cancer Diagnosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.